Literature DB >> 8445772

Isolation of Yersinia enterocolitica (0:5,27 biotype 2) from a common garter snake.

J Kwaga1, J O Iversen.   

Abstract

Yersinia enterocolitica serotype 0:5,27 biotype 2 was isolated from the intestinal contents of a common garter snake (Thamnophis sirtalis). The isolate possessed virulence associated phenotypes in all tests conducted. It was susceptible to amikacin, ampicillin/sulbactam, aztreonam, cefoperazone, cefotaxime, ceftazidime, ceftriaxone, cefuroxime, ciprofloxacin, gentamicin, imipenem, mezlocillin, norfloxacin, piperacillin, ticarcillin/clavulanic acid, trimethoprim-sulfamethoxazole, tobramycin, chloramphenicol and tetracycline. The isolate harbored the virulence plasmid.

Entities:  

Mesh:

Year:  1993        PMID: 8445772     DOI: 10.7589/0090-3558-29.1.127

Source DB:  PubMed          Journal:  J Wildl Dis        ISSN: 0090-3558            Impact factor:   1.535


  4 in total

1.  An outbreak of Yersinia enterocolitica in a captive colony of African green monkeys (Chlorocebus aethiops sabaeus) in the Caribbean.

Authors:  Esteban Soto; Matt Griffin; Ashutosh Verma; Fernanda Castillo-Alcala; Amy Beierschmitt; Janet Beeler-Marfisi; Maziel Arauz; Oscar Illanes
Journal:  Comp Med       Date:  2013-10       Impact factor: 0.982

2.  Investigation of a Yersinia enterocolitica outbreak in a commercial alpaca farm in Saskatchewan.

Authors:  Valentina M Ragno; Fabienne D Uehlinger; Kamal Gabadage; Ahmad R Movasseghi; Julia B Montgomery
Journal:  Can Vet J       Date:  2019-08       Impact factor: 1.008

Review 3.  Yersinia enterocolitica: the charisma continues.

Authors:  E J Bottone
Journal:  Clin Microbiol Rev       Date:  1997-04       Impact factor: 26.132

4.  Multispecies Epidemiologic Surveillance Study after an Outbreak of Yersiniosis at an African Green Monkey Research Facility.

Authors:  Esteban Soto; Amanda Loftis; Daniel Boruta; Sara Rostad; Amy Beierschmitt; Matthew McCoy; Stewart Francis; John Berezowski; Oscar Illanes; Diego Recinos; Maziel Arauz; Dustine Spencer; Trellor Fraites; Roberta Palmour
Journal:  Comp Med       Date:  2015-12       Impact factor: 0.982

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.